|
| 37039790 | Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. | JAMA | 2023 |
| 37704336 | Designing and Implementing "Living and Breathing" Clinical Trials: An Overview and Lessons Learned from the COVID-19 Pandemic. | Crit Care Clin | 2023 |
| 37419639 | Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): a pilot clinical trial protocol. | BMJ Open | 2023 |
| 37052436 | Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations. | Crit Care Med | 2023 |
| 37052435 | Executive Summary: Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations. | Crit Care Med | 2023 |
| 37011399 | Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study. | Ann Intern Med | 2023 |
| 34812069 | Shock Index, Modified Shock Index and MELD as Predictors of Mortality for Critically Ill Patients With Liver Disease. | J Intensive Care Med | 2022 |
| 35583867 | Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging. | JAMA Netw Open | 2022 |
| 35767924 | Comparison of the prognostic performance of the CURB-65 and a modified version of the pneumonia severity index designed to identify high-risk patients using the International Community-Acquired Pneumonia Collaboration Cohort. | Respir Med | 2022 |
| 35834252 | Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial. | JAMA Netw Open | 2022 |
| 35606829 | The NICU Antibiotics and Outcomes (NANO) trial: a randomized multicenter clinical trial assessing empiric antibiotics and clinical outcomes in newborn preterm infants. | Trials | 2022 |
| 35697146 | The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial. | Contemp Clin Trials | 2022 |
| 35860323 | A learning health system approach to the COVID-19 pandemic: System-wide changes in clinical practice and 30-day mortality among hospitalized patients. | Learn Health Syst | 2022 |
| 36590348 | Development and implementation of the National Heart, Lung, and Blood Institute COVID-19 common data elements. | J Clin Transl Sci | 2022 |
| 36324319 | Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era. | Open Forum Infect Dis | 2022 |
| 35315874 | Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. | JAMA | 2022 |
| 34896293 | Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21Â days. | Contemp Clin Trials | 2022 |
| 32347324 | Biomarkers in the ICU: less is more? Yes. | Intensive Care Med | 2021 |
| 33906105 | Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome. | J Crit Care | 2021 |
| 33616663 | Feasibility of Embedding a Scalable, Virtually Enabled Biorepository in the Electronic Health Record for Precision Medicine. | JAMA Netw Open | 2021 |
| 33506231 | Outcomes of end-stage renal disease patients in the PROCESS trial. | J Am Coll Emerg Physicians Open | 2021 |
| 34606578 | Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. | JAMA | 2021 |
| 34651137 | A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis. | Crit Care Explor | 2021 |
| 34351721 | Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. | N Engl J Med | 2021 |
| 34250192 | Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | Open Forum Infect Dis | 2021 |
| 34034784 | The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. | Trials | 2021 |
| 31148210 | Rationale for and Design of the Study of Early Enteral Dextrose in Sepsis: A Pilot Placebo-Controlled Randomized Clinical Trial. | JPEN J Parenter Enteral Nutr | 2020 |
| 31971839 | Emergency Medical Services Care and Sepsis Trajectories. | Prehosp Emerg Care | 2020 |
| 32058387 | Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations. | Crit Care Med | 2020 |
| 32058375 | Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary and Renal Considerations: Executive Summary. | Crit Care Med | 2020 |
| 31995699 | Longer-Term Outcomes of the ProACT Trial. | N Engl J Med | 2020 |
| 31733680 | Procalcitonin: Where Are We Now? | Crit Care Clin | 2020 |
| 32809003 | Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial. | JAMA | 2020 |
| 32391157 | Monocyte distribution width enhances early sepsis detection in the emergency department beyond SIRS and qSOFA. | J Intensive Care | 2020 |
| 31588983 | Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. | Intensive Care Med | 2020 |
| 30407869 | Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure. | Ann Am Thorac Soc | 2019 |
| 31852712 | Ascorbic Acid, Corticosteroids and Thiamine in Sepsis (ACTS) protocol and statistical analysis plan: a prospective, multicentre, double-blind, randomised, placebo-controlled clinical trial. | BMJ Open | 2019 |
| 31679153 | Erratum to: Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome. | Semin Respir Crit Care Med | 2019 |
| 31060092 | Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome. | Semin Respir Crit Care Med | 2019 |
| 31104070 | Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. | JAMA | 2019 |
| 30392734 | Is Normal Saline Solution an Acceptable Choice of Fluid for Stable Patients? | Ann Emerg Med | 2019 |
| 28669553 | Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency Care. | Ann Emerg Med | 2018 |
| 30458880 | Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial. | Crit Care | 2018 |
| 30373647 | Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation. | Crit Care | 2018 |
| 30395128 | Rectal Trumpet-Associated Hemorrhage in the Intensive Care Unit: A Quality Improvement Initiative. | J Wound Ostomy Continence Nurs | 2018 |
| 29781385 | Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection. | N Engl J Med | 2018 |
| 29324189 | Is Cisatracurium the Neuromuscular Blocking Agent of Choice in Acute Respiratory Distress Syndrome? | Am J Respir Crit Care Med | 2018 |
| 27779896 | Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome. | Ann Am Thorac Soc | 2017 |
| 28109962 | Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial. | Chest | 2017 |
| 28079606 | Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock Study. | Crit Care Med | 2017 |